The Progress In Research Ontargeted And Immunotherapy For Non-Small Cell Lung Cancer
The incidence and mortality rates of non-small cell lung cancer (NSCLC) are alarmingly high, positioning it as one of the most critical diseases that require immediate attention. This paper first outlines the current status of NSCLC, followed by a discussion of traditional treatment modalities, incl...
Saved in:
| Main Author: | Qian Zijia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | BIO Web of Conferences |
| Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/33/bioconf_icfsb2025_02003.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer
by: Jing Cheng, et al.
Published: (2025-02-01) -
Immunotherapy for Extensive-stage Small Cell Lung Cancer:
Research Progress and Future Perspectives
by: Yuling ZHONG, et al.
Published: (2024-11-01) -
Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01) -
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
by: Emily Wolf, et al.
Published: (2025-01-01) -
The role of immunotherapy in resectable non-small-cell lung cancer
by: Conor D. Moloney, et al.
Published: (2025-08-01)